menu
    • menu
    [{"orgOrder":0,"company":"PATH","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh | Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh | Aragen Life Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Paromomycin Sulfate","moa":"Bacterial 70S ribosome","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"PATH","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"PATH \/ International Centre for Diarrhoeal Disease Research, Bangladesh | Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh | Aragen Life Sciences","highestDevelopmentStatusID":"1","companyTruncated":"PATH \/ International Centre for Diarrhoeal Disease Research, Bangladesh | Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh | Aragen Life Sciences"},{"orgOrder":0,"company":"Appili Therapeutics","sponsor":"Undisclosed","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Antibiotic","year":"2025","type":"Private Placement","leadProduct":"Paromomycin Sulfate","moa":"Bacterial 70S ribosome","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Appili Therapeutics","amount2":0.01,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0.01,"dosageForm":"Cream","sponsorNew":"Appili Therapeutics \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Appili Therapeutics \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Paromomycin Sulfate

    Menu

    Paromomycin Sulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Appili Therapeutics

                            Canada arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Appili Therapeutics

                            Canada arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Paromomycin Sulfate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : $11.6 million

                            Deal Type : Private Placement

                            DEALS_DEV arrow-down

                            Appili Therapeutics Closes First Tranche of Private Placement

                            Details : In a private placement deal, Paromomycin Sulfate will be funded to target the bacterial 70S ribosome, addressing cutaneous leishmaniasis.

                            Product Name : ATI-1801

                            Product Type : Antibiotic

                            Upfront Cash : Undisclosed

                            December 18, 2025

                            Lead Product(s) : Paromomycin Sulfate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : $11.6 million

                            Deal Type : Private Placement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            PATH

                            Country arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            PATH

                            Country arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Paromomycin Sulfate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : International Centre for Diarrhoeal Disease Research, Bangladesh | Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh | Aragen Life Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in ...

                            Details : Paromomycin Sulfate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Leishmaniasis, Visceral.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            April 04, 2011

                            Lead Product(s) : Paromomycin Sulfate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : International Centre for Diarrhoeal Disease Research, Bangladesh | Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh | Aragen Life Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.